New Jersey, USA-based Merck & Co has announced it will present 140 abstracts at the upcoming annual meeting of the Annual Society of Clinical Oncology (ASCO), i 17 May 2019
After a slow start, there have been better recent sales of Yescarta (axicabtagene ciloleucel), the CAR-T therapy that Gilead Sciences picked up in its $11.9 bil 16 May 2019
London-listed AstraZeneca has revealed details of what it will present at the upcoming annual meeting of the American Society of Clinical Oncology (ASCO) at the 16 May 2019
Ipsen (Euronext: IPN) has been in oncology for a long time — since the 1980s in fact. It's one of the field's top 20 companies. But in a market that’s turbulent 15 June 2018
Data presented on the Folfirinox chemotherapy regimen at the American Society of Clinical Oncology (ASCO) has spelt the end for Targovax’s TG01, a neoantigen ca 13 June 2018
The pressure for companies with cancer assets to come to the party at the American Society of Clinical Oncology (ASCO) Annual Meeting with impressive data prese 5 June 2018
A combination of Imbruvica (ibrutinib) and Rituxan/MabThera (Rituxan) has shown greater efficacy than the latter drug alone in patients with Waldenström’s macro 5 June 2018
Presenting at the annual meeting of the American Society of Clinical Oncology (ASCO), France’s Sanofi and US-based Regeneron Pharmaceuticals have released new p 5 June 2018
Shares in US biotech Nektar Therapeutics were down by as much as 40% after the morning's trading on Monday as markets mulled over news on its development of NKT 4 June 2018
There are plenty of immuno-oncology (I-O) drugs in development and Bristol-Myers Squibb’s (NYSE: BMY) Opdivo (nivolumab) is the current best-seller of those on 4 June 2018
Data revealed at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting on Saturday offered a promising signal for AstraZeneca’s antibody drug con 4 June 2018
At the American Society for Clinical Oncology (ASCO) conference on Friday, Samsung Bioepis (KRX: 207940) revealed the results of a one-year follow-up study on S 1 June 2018
This week, cancer patients, oncologists and investors alike look ahead to the annual meeting of the American Society of Clinical Oncology (ASCO), which kicks of 29 May 2018
At an unusually quiet annual meeting of the American Society of Clinical Oncology, Joanne Lager and Israel Lowy, the oncology heads of Sanofi (Euronext: SAN) an 12 June 2017
With so much of the exciting data at ASCO 2017 again surrounding cancer immunotherapies, The Pharma Letter finds confidence that more will follow in the footste 8 June 2017
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.